APA (7th ed.) Citation

KT, L., TM, C., CJ, C., & JF, L. (2026). Integrative Bulk and Single-Nucleus Analyses Nominate COL5A2 as a CAF/ECM-Associated Marker Associated with PDAC Progression. Diagnostics (Basel, Switzerland), 16(8), . https://doi.org/10.3390/diagnostics16081205

Chicago Style (17th ed.) Citation

KT, Lu, Chang TM, Chang CJ, and Liu JF. "Integrative Bulk and Single-Nucleus Analyses Nominate COL5A2 as a CAF/ECM-Associated Marker Associated with PDAC Progression." Diagnostics (Basel, Switzerland) 16, no. 8 (2026). https://doi.org/10.3390/diagnostics16081205.

MLA (9th ed.) Citation

KT, Lu, et al. "Integrative Bulk and Single-Nucleus Analyses Nominate COL5A2 as a CAF/ECM-Associated Marker Associated with PDAC Progression." Diagnostics (Basel, Switzerland), vol. 16, no. 8, 2026, https://doi.org/10.3390/diagnostics16081205.